09-JUL-2026 6:10

LUNG ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S2409-ESCLC, Durvalumab +/- Biomarker Directed Tx 1 Y 0 Screening & Cohort Assignment 900 45 45 36 21 6 2 11/06/2025 232 69
            45 45 36 21 6 2      
 
    2 Y 1 Durvalumab   5 5 5 3 1 0 11/06/2025    
        2 Durvalumab + Saruparib   3 3 3 1 0 0      
        5 Durvalumab   1 1 1 1 0 0      
        6 Durvalumab + Monalizumab   1 1 1 1 1 0      
            10 10 10 6 2 0      
 
  S2414-NSCLC, Stg II-IIIB, Durva vs Surveillance 1 Y 1 Durvalumab 306 6 4 3 2 1 0 04/01/2025 271 86
        2 Surveillance   6 5 4 2 2 2      
            12 9 7 4 3 2      
 
Yes A081801-ALCHEMIST4, ALK and EGFR negative, Chemo-IO 1 E Total Registrations   109 17 8 4 1 0 10/20/2020 434 166
            109 17 8 4 1 0      
 
  EA5162-NSCLC,StgIV/IIB,EGFR exon20 insertion,AZD9291 1 E Total Registrations   4 0 0 0 0 0 08/23/2023 89 33
            4 0 0 0 0 0      
 
  EA5182-NSCLC, Met EGFR mut, AZD9291+Beva vs AZD9291 1 E Total Registrations   26 2 1 0 0 0 04/28/2021 235 84
            26 2 1 0 0 0      
 
  EA5221-Lung, Advanced NSCLC, ChemoImmuno/Immuno 1 E Total Registrations   5 2 0 0 0 0 08/07/2024 219 81
            5 2 0 0 0 0      
 
    2 E Total Registrations   4 2 0 0 0 0 08/07/2024    
            4 2 0 0 0 0      
 
  NRGLU008-Lung NSCL, StgII-III, StereoBodyRad/MedChemo 1 E Total Registrations   5 2 0 0 0 0 01/26/2024 344 131
            5 2 0 0 0 0      
 
No S2402-NSCLC, All Stg, Periop Vs Adj Tx 1 E Total Registrations   8 4 2 0 0 0 04/22/2025 146 67
            8 4 2 0 0 0      
 
  A082002-Lung, Adv, Systemic Tx +/- SBRT 1 E Total Registrations   4 0 0 0 0 0 10/12/2022 256 74
            4 0 0 0 0 0